Browse the complete record of transactions filed by Dinsmore Christopher, Directeur Scientifique. Officer active across 1 companies, notably Kronos Bio, Inc.. In total, 10 filings have been published. Total volume traded: €245k. The latest transaction was filed on 15 February 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Christopher Dinsmore is the Chief Scientific Officer at Kronos Bio, Inc. He oversees the company's research and development, ensuring innovation and scientific advancement. His expertise is essential for Kronos's success in the biopharmaceutical field.